JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 5 April 2004. doi:10.1083/jcb1651rr2
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 165, Number 1, 16-16
This Article
Right arrow Full Text (PDF, 1042K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Roundup

Cholesterol hastens Alzheimer's



Aß aggregates (white) form faster in the presence (right) of cholesterol aldehydes.

Kelly/NAS

Results from Qinghai Zhang, Jeffery Kelly (Scripps Research Institute, La Jolla, CA), and colleagues suggest that evil metabolites may accelerate Alzheimer's disease (AD) by promoting protein misfolding. This folding effect may explain why inflammation and high cholesterol are risk factors for AD.

AD results from aggregates of a misfolded form of amyloid ß peptide (Aß). Misfolding occasionally results from processing flaws or mutations in the Aß precursor, but most patients have normal Aß. Zhang et al. show that even normal Aß folds abnormally when cholesterol by-products modify it.

Cholesterol itself did not affect Aß, but cholesterol modified by reactive oxygen species (which are produced during inflammation) to generate an aldehyde group reacted with Aß and made it more hydrophobic. This altered form aggregates at much lower concentrations than does normal Aß–concentrations that are found in the brain.

Although brain samples did not show higher levels of the cholesterol aldehydes in AD patients, only small amounts of these metabolites are needed to jump start aggregation. "The creation of compounds that are reactive could be from an event occurring years before an individual presents with AD," says Kelly. So, as boxers already know, one good knock on the head might do more lasting damage than just a fleeting headache. {blacksquare}

Reference:

Zhang, Q., et al. 2004. Proc. Natl. Acad. Sci. USA. 10.1073/pnas.0400924101.



Nicole LeBrasseur

lebrasn{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 1042K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents